DexCom, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $917.7M | $606.1M | $566.3M | $642.3M | $1.05B | $817.6M | $446.2M | $1.14B |
| Accounts Receivable | $1.22B | $1.01B | $973.9M | $713.3M | $514.3M | $428.5M | $286.3M | $226.7M |
| Inventory | $629.1M | $542.6M | $559.6M | $306.7M | $357.3M | $234.7M | $119.8M | $70.7M |
| Total Current Assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B | $3.42B | $1.97B | $1.70B |
| Property, Plant & Equipment | — | — | — | — | $801.8M | $515.3M | $321.3M | $183.1M |
| Goodwill | $24.2M | $22.8M | $25.2M | $25.7M | $26.5M | $19.3M | $18.6M | $18.7M |
| Intangible Assets (Excl. Goodwill) | $70.8M | $103.4M | $134.5M | $173.3M | $31.5M | — | — | — |
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B |
| Liabilities | ||||||||
| Accounts Payable | $344.3M | $345.3M | $276.4M | $237.9M | $189.4M | $163.3M | $102.3M | $75.5M |
| Total Current Liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $720.8M | $614.1M | $360.2M | $222.4M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B | $1.51B | $1.25B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $2.43B | $1.60B | $1.02B | $479.9M | $138.7M | $-78.2M | $-695.7M | $-798.9M |
| Total Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.55B | $882.6M | $663.3M |